Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Lin, Albert Y ^a,b   Chua, Mei Sze ^c   Choi, Yoon La ^b,d   Yeh, William ^a   Kim, Young H ^b   Azzi, Raymond ^a   Adams, Gregg A ^a   Sainani, Kristin ^c   van de Rijn, Matt ^b   So, Samuel K ^c   Pollack, Jonathan R ^b  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOID ENHANCER FACTOR 1; OSTEOPONTIN; TUMOR MARKER; LEF1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; UPREGULATION; VISCERAL METASTASIS; CARCINOMA; CLUSTER ANALYSIS; COLORECTAL TUMOR; COMPARATIVE STUDY; GENETICS; ISOLATION AND PURIFICATION; LIVER TUMOR; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952077027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016636     Document Type: Article

References (49)

1. Markowitz SD, Bertagnolli MM, (2009) Molecular Basis of Colorectal Cancer. N Engl J Med 361: 2449-2460.
2. Jemal A, Ward E, Thun M, (2010) Declining Death Rates Reflect Progress against Cancer. PLoS One 5: e9584.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer Statistics, 2009. CA Cancer J Clin 59: 225-249.
4. Greenlee RT, Hill-Harmon MB, Murray T, Thun M, (2001) Cancer statistics, 2001. CA Cancer J Clin 51: 15-36.
5. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH, (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318.
6. Jarnagin WR, Conlon K, Bodniewicz J, Dougherty E, DeMatteo RP, et al. (2001) A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91: 1121-1128.
7. Pollack JR, (2007) A Perspective on DNA Microarrays in Pathology Research and Practice. Am J Pathol 171: 375-385.
8. Notterman DA, Alon U, Sierk AJ, Levine AJ, (2001) Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130.
9. Friederichs J, Rosenberg R, Mages J, Janssen K-P, Maeckl C, et al. (2005) Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Int J Colorectal Dis 20: 391-402.
10. Inokuchi M, Uetake H, Shirota Y, Yamada H, Tajima M, et al. (2004) Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis. Cancer Chemother Pharmacol 53: 391-396.
11. Matsuyama R, Togo S, Shimizu D, Momiyama N, Ishikawa T, et al. (2006) Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer 119: 406-413.
12. Chen X, Cheung ST, So S, Fan ST, Barry C, et al. (2002) Gene expression patterns in human liver cancers. Mol Biol Cell 13: 1929-1939.
13. Rangaswami H, Bulbule A, Kundu GC, (2006) Osteopontin: role in cell signaling and cancer progression. Trends in Cell Biology 16: 79-87.
14. Li TW-H, Ting J-HT, Yokoyama NN, Bernstein A, van de Wetering M, et al. (2006) Wnt Activation and Alternative Promoter Repression of LEF1 in Colon Cancer. Mol Cell Biol 26: 5284-5299.
15. Ramaswamy S, Ross KN, Lander ES, Golub TR, (2003) A molecular signature of metastasis in primary solid tumors. Nature Genetics Nature Publishing Group.
16. Travis A, Amsterdam A, Belanger C, Grosschedl R, (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev 5: 880-894.
17. Waterman ML, Fischer WH, Jones KA, (1991) A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev 5: 656-669.
18. Cadigan KM, Nusse R, (1997) Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305.
19. Bienz M, Clevers H, (2000) Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
20. Nusse R, (1999) WNT targets: repression and activation. Trends in Genetics 15: 1-3.
21. Fuerer C, Nusse R, Ten Berge D, (2008) Wnt signalling in development and disease. Max Delbruck Center for Molecular Medicine meeting on Wnt signaling in Development and Disease. EMBO Rep 9: 134-138.
22. Schneikert J, Behrens J, (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56: 417-425.
23. Hovanes K, Li TWH, Munguia JE, Truong T, Milovanovic T, et al. (2001) β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nature Genetics 28: 53.
24. Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL, (2004) Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 10: 1401-1408.
25. Prince C, Oosawa T, Butler W, Tomana M, Bhown A, et al. (1987) Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 262: 2900-2907.
26. Tuck AB, Chambers AF, Allan AL, (2007) Osteopontin overexpression in breast cancer: Knowledge gained and possible implications for clinical management. Journal of Cellular Biochemistry 102: 859-868.
27. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, et al. (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521.
28. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, et al. (2003) Osteopontin identified as colon cancer tumor progression marker. C R Biol 326: 1041-1043.
29. Yeatman TJ, Chambers AF, (2003) Osteopontin and colon cancer progression. Clin Exp Metastasis 20: 85-90.
30. Rohde F, Rimkus C, Friederichs J, Rosenberg R, Marthen C, et al. (2007) Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer. Int J Cancer 121: 1717-1723.
31. Muller A, Homey B, Soto H, Ge N, Catron D, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
32. Zeelenberg IS, Ruuls-Van Stalle L, Roos E, (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63: 3833-3839.
33. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, et al. (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226.
34. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
35. Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, et al. (2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121: 2005-2012.
36. Kleivi K, Lind GE, Diep CB, Meling GI, Brandal LT, et al. (2007) Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer 6: 2.
37. Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, et al. (2004) Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24: 305-312.
38. Lin HM, Chatterjee A, Lin YH, Anjomshoaa A, Fukuzawa R, et al. (2007) Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncol Rep 17: 1541-1549.
39. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW Jr, et al. (2004) Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23: 7366-7377.
40. Tackels-Horne D, Goodman MD, Williams AJ, Wilson DJ, Eskandari T, et al. (2001) Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer 92: 395-405.
41. Takahashi Y, Ishii Y, Nishida Y, Ikarashi M, Nagata T, et al. (2006) Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH. Cancer Genet Cytogenet 168: 30-35.
42. Takata O, Kawamura YJ, Konishi F, Sasaki J, Kai T, et al. (2006) cDNA Array Analysis for Prediction of Hepatic Metastasis of Colorectal Carcinoma. Surgery Today 36: 608-614.
43. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y, (2006) Colorectal cancer: genetics of development and metastasis. J Gastroenterol 41: 185-192.
44. Yanagawa R, Furukawa Y, Tsunoda T, Kitahara O, Kameyama M, et al. (2001) Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia 3: 395.
45. Quackenbush J, (2006) Microarray analysis and tumor classification. N Engl J Med 354: 2463-2472.
46. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, et al. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 101: 811-816.
47. Demeter J, Beauheim C, Gollub J, Hernandez-Boussard T, Jin H, et al. (2007) The Stanford Microarray Database: implementation of new analysis tools and open source release of software. Nucleic Acids Res 35: D766-770.
48. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
49. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.